Patient Guide: A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 101 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05620836
Status: ACTIVE_NOT_RECRUITING
Condition: Hidradenitis Suppurativa (HS)
Phase: PHASE3

Where You Can Participate

This study is available at 101 locations across the country.

Top locations include:
  • • Scottsdale, Arizona
  • • Scottsdale, Arizona
  • • Arkansas, Arkansas
  • • And 98 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS) - Join Clinical Trial NCTNCT05620836

How to Join This Clinical Trial - NCTNCT05620836

Learn how to participate in this PHASE3 trial studying an investigational therapy for Hidradenitis Suppurativa (HS). Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Hidradenitis Suppurativa (HS). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Hidradenitis Suppurativa (HS)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05620836 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 101 locations. Find a study site near you:

Clinical Research Site

Scottsdale, Arizona 85255 - United States

Status: Contact for availability

Clinical Research Site

Scottsdale, Arizona 85259 - United States

Status: Contact for availability

Clinical Research Site

Arkansas, Arkansas 72758 - United States

Status: Contact for availability

Clinical Research Site

Fayetteville, Arkansas 72703 - United States

Status: Contact for availability

Clinical Research Site

Los Angeles, California 90033 - United States

Status: Contact for availability

Clinical Research Site

San Diego, California 92103 - United States

Status: Contact for availability

Clinical Research Site

San Francisco, California 94118 - United States

Status: Contact for availability

Clinical Research Site

Washington, District of Columbia 20060 - United States

Status: Contact for availability

Clinical Research Site

Brandon, Florida 33511 - United States

Status: Contact for availability

Clinical Research Site

Margate, Florida 33063 - United States

Status: Contact for availability

And 91 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Hidradenitis Suppurativa (HS):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships